Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by NSX001on Jun 06, 2022 10:31am
238 Views
Post# 34733917

RE:Step closer

RE:Step closerHi JACKTHEBEAR, I'm as exited as everyone else here as to where this is going, that's why I'm here. And I don't want to be "that" guy who malignes the company at every opportunity. But I think it's going to take more than fluff news to move this past the long standing .06 cent basement that it's stuck in.

I beleive that in the near term, the REDUVO DIN approval will do the job, by quaranteeing some much needed revenue, and thus stopping the constant raising of money with cheap shares.
The longer term rocket launch will take the QIXLEEF approval or to a smaller degree the announcement of the finalizing of level two.

With the number of shares outstanding, nothing else is not going to make a differnce. There's a constant supply of cheap shares available for sale, it's going to be hard to move the needle up.

NSX001

<< Previous
Bullboard Posts
Next >>